396 related articles for article (PubMed ID: 6380902)
21. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
22. Cefotaxime: microbiology, pharmacology, and clinical use.
Dudley MN; Barriere SL
Clin Pharm; 1982; 1(2):114-24. PubMed ID: 6309465
[TBL] [Abstract][Full Text] [Related]
23. [Monotherapy of systematic Pseudomonas aeruginosa infections with ceftazidime. The causes of therapeutic failures].
Blaser J; Bauernfeind A; Vogt M; Lüthy R
Dtsch Med Wochenschr; 1983 Sep; 108(35):1312-7. PubMed ID: 6411442
[TBL] [Abstract][Full Text] [Related]
24. [Comparative bactericidal activity of cefsulodin and ceftazidime on Pseudomonas aeruginosa].
Delisle-Mizon F; Lesage D; Denis C; Vergez P; Daguet GL
Pathol Biol (Paris); 1983 May; 31(5):383-6. PubMed ID: 6413938
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of Pseudomonas infections in children with cefsulodin (author's transl)].
Rosenkranz A
Wien Med Wochenschr; 1981 Oct; 131(20):511-4. PubMed ID: 7314634
[TBL] [Abstract][Full Text] [Related]
26. [Concomitant therapy with cefmenoxime and cefsulodin for refractory complicated urinary tract infection (especially caused by Pseudomonas aeruginosa)].
Ishigami J; Fujii A; Harada M; Arakawa S; Umezu K; Kawabata G; Kataoka N; Kamidono S; Miyazaki S; Takasaki N
Hinyokika Kiyo; 1986 May; 32(5):779-88. PubMed ID: 3463188
[TBL] [Abstract][Full Text] [Related]
27. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
[TBL] [Abstract][Full Text] [Related]
28. Aztreonam, a new monobactam antimicrobial.
Guay DR; Koskoletos C
Clin Pharm; 1985; 4(5):516-26. PubMed ID: 3902330
[TBL] [Abstract][Full Text] [Related]
29. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
Babalola CP; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
[TBL] [Abstract][Full Text] [Related]
30. Cefsulodin.
Wright DB
Drug Intell Clin Pharm; 1986 Nov; 20(11):845-9. PubMed ID: 3536385
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial activity, pharmacokinetics, therapeutic indications and adverse reactions of ceftazidime.
Gentry LO
Pharmacotherapy; 1985; 5(5):254-67. PubMed ID: 3906585
[TBL] [Abstract][Full Text] [Related]
32. Cephalosporin antibiotics as applied in surgery of bones and joints.
Neu HC
Clin Orthop Relat Res; 1984 Nov; (190):50-64. PubMed ID: 6386261
[TBL] [Abstract][Full Text] [Related]
33. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
34. Cefsulodin treatment for serious Pseudomonas aeruginosa infections.
Routman A; Van Manen W; Haddad R; Pollock B; Holmes B; Mogabgab WJ
J Int Med Res; 1986; 14(5):242-53. PubMed ID: 3770290
[TBL] [Abstract][Full Text] [Related]
35. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
Dureux JB; Canton P; Roche G; Weber M; Gérard A
Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
[TBL] [Abstract][Full Text] [Related]
36. Cefepime.
Hardin TC; Jennings TS
Pharmacotherapy; 1994; 14(6):657-68. PubMed ID: 7885968
[TBL] [Abstract][Full Text] [Related]
37. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
Thabaut A; Meyran M
Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
[TBL] [Abstract][Full Text] [Related]
38. [In vivo-acquired resistance to cefsulodin by a strain of Pseudomonas aeruginosa].
Jouvenot M; Michel-Briand Y; Dupont MJ; Cattin J
Pathol Biol (Paris); 1984 May; 32(5):426-8. PubMed ID: 6429615
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
Ishibashi K; Yamaguchi O; Shiraiwa Y; Ogihara M; Shigeta S
J Urol; 1996 Jun; 155(6):2094-7. PubMed ID: 8618343
[TBL] [Abstract][Full Text] [Related]
40. The selection and use of cephalosporins: a review.
Klein NC; Cunha BA
Adv Ther; 1995; 12(2):83-101. PubMed ID: 10150326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
